We are live on
!
Find out more
BFA
BlackRock Fund Advisors Portfolio holdings
AUM
$542B
1-Year Est. Return
18.13%
This Fund
S&P 500
This Quarter
Est. Return
+0.29%
1 Year Est. Return
+18.13%
3 Year Est. Return
+41.39%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$417B
AUM Growth
-$1.66B
(-0.4%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
0.46%
Top 10 Holdings %
Top 10 Hldgs %
9.45%
Holding
4,011
New
140
Increased
1,618
Reduced
1,966
Closed
139
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Germany ETF
EWG
|
+$739M |
| 2 |
iShare MSCI Eurozone ETF
EZU
|
+$723M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$662M |
| 4 |
iShares MSCI Japan ETF
EWJ
|
+$452M |
| 5 |
Jazz Pharmaceuticals
JAZZ
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LO
LORILLARD INC COM STK
LO
|
+$553M |
| 2 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$381M |
| 3 |
Qorvo
QRVO
|
+$377M |
| 4 |
TEG
INTEGRYS ENERGY GROUP INC COM (USA)
TEG
|
+$319M |
| 5 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.1% |
| 2 | Financials | 12.85% |
| 3 | Technology | 12.68% |
| 4 | Industrials | 10.63% |
| 5 | Consumer Discretionary | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRT
3476
DELISTED
Startek Inc.
SRT
| $217K | ﹤0.01% |
36,703
-4,831
| -12% | -$33.6K |
|
|
RSYS
3477
DELISTED
Radisys Corp
RSYS
| $217K | ﹤0.01% |
84,677
+7,392
| +10% | +$18.2K |
|
3478
Actinium Pharmaceuticals
ATNM
$27.2M
| $216K | ﹤0.01% |
2,713
-18,500
| -87% | -$1.58M |
|
3479
Perspective Therapeutics
CATX
$327M
| $216K | ﹤0.01% |
14,587
-304
| -2% | -$4.93K |
|
3480
Tandy Leather Factory
TLF
$19.4M
| $216K | ﹤0.01% |
25,064
| – | – |
|
|
AVGR
3481
DELISTED
Avinger, Inc. Common Stock
AVGR
| – | – |
0
| – | – |
|
3482
AngloGold Ashanti
AU
$39.9B
| $215K | ﹤0.01% |
24,048
-36,309
| -60% | -$368K |
|
3483
Ark Restaurants
ARKR
$20.6M
| $214K | ﹤0.01% |
8,558
-2,424
| -22% | -$60.3K |
|
|
UCP
3484
DELISTED
UCP, Inc.
UCP
| $214K | ﹤0.01% |
28,286
-194,822
| -87% | -$1.63M |
|
3485
AmeriServ Financial
ASRV
$75.8M
| $213K | ﹤0.01% |
64,010
+7,723
| +14% | +$25.2K |
|
3486
RCM Technologies
RCMT
$205M
| $213K | ﹤0.01% |
37,695
-3,029
| -7% | -$18K |
|
3487
Friedman Industries
FRD
$264M
| $212K | ﹤0.01% |
33,842
+4,070
| +14% | +$26.4K |
|
3488
Gyre Therapeutics
GYRE
$668M
| $212K | ﹤0.01% |
96
-8
| -8% | -$16K |
|
|
EDGW
3489
DELISTED
Edgewater Technology Inc
EDGW
| $212K | ﹤0.01% |
29,051
-168
| -0.6% | -$1.2K |
|
3490
NanoViricides
NNVC
$37M
| $211K | ﹤0.01% |
6,106
-53,902
| -90% | -$2.05M |
|
|
EGLT
3491
DELISTED
Egalet Corporation
EGLT
| $211K | ﹤0.01% |
14,654
-83,294
| -85% | -$914K |
|
3492
Sterling Infrastructure
STRL
$16.5B
| $210K | ﹤0.01% |
52,596
-469,172
| -90% | -$1.89M |
|
|
VYNT
3493
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
| $209K | ﹤0.01% |
119
+15
| +14% | +$23.3K |
|
|
QUMU
3494
DELISTED
Qumu Corp.
QUMU
| $209K | ﹤0.01% |
25,380
-4,206
| -14% | -$45K |
|
|
CFRX
3495
DELISTED
ContraFect Corporation
CFRX
| $209K | ﹤0.01% |
+50
| New | +$203K |
|
3496
Aviat Networks
AVNW
$264M
| $208K | ﹤0.01% |
27,558
-996
| -3% | -$7.09K |
|
|
SPRT
3497
DELISTED
support.com, Inc.
SPRT
| $208K | ﹤0.01% |
49,227
-370
| -0.7% | -$1.69K |
|
|
FSYS
3498
DELISTED
FUEL SYSTEMS SOLUTIONS INC COM STK
FSYS
| $208K | ﹤0.01% |
27,827
-356,366
| -93% | -$3.31M |
|
|
CBIO
3499
Crescent Biopharma
CBIO
$608M
| $207K | ﹤0.01% |
261
+32
| +14% | +$26.5K |
|
3500
InfuSystem Holdings
INFU
$200M
| $206K | ﹤0.01% |
64,723
-884
| -1% | -$2.76K |
|
Similar funds
BIT
BG
BA
BIM
BJ
IC
EAM
MFS
BlackRock Fund Advisors's Q2 2015 Portfolio in Review
As of Q2 2015, BlackRock Fund Advisors held 4,011 positions worth $417B, down 0.4% from $419B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
BlackRock Fund Advisors's Q2 2015 filing shows 140 new, 1,618 increased, 1,966 reduced and 139 closed positions. Its largest new stake was Jazz Pharmaceuticals: 1,516,810 shares worth $267M. The largest sale was LORILLARD INC COM STK, an estimated $553M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Financials and Technology.
- BlackRock Fund Advisors's largest Q2 2015 buy was Jazz Pharmaceuticals: 1,516,810 shares worth $267M.
- BlackRock Fund Advisors added most to iShares MSCI Germany ETF in Q2 2015, an estimated $739M increase.
- BlackRock Fund Advisors's biggest Q2 2015 reduction was Qorvo, cutting an estimated $377M.
- BlackRock Fund Advisors fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $553M.
- BlackRock Fund Advisors's ten largest holdings make up 9.5% of its $417B portfolio in Q2 2015.
- BlackRock Fund Advisors opened 140 new positions and closed 139 in Q2 2015.
- BlackRock Fund Advisors's portfolio value fell 0.4% quarter-over-quarter to $417B.
Based on BlackRock Fund Advisors's 13F filing for Q2 2015, filed 7 Aug 2015.